Picture of Liminal BioSciences logo

LMNL — Liminal BioSciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Brief: Liminal Biosciences Confirms Receipt Of Unsolicited Non-Binding Transaction Proposal

April 5 (Reuters) - Liminal BioSciences Inc:
    * LIMINAL BIOSCIENCES CONFIRMS RECEIPT OF UNSOLICITED
NON-BINDING
TRANSACTION PROPOSAL
    * LIMINAL BIOSCIENCES INC - SALP CURRENTLY OWNS
APPROXIMATELY
64.03% OF COMPANY'S CURRENTLY OUTSTANDING COMMON SHARES
    * LIMINAL BIOSCIENCES INC - RECEIVED A NON-BINDING PROPOSAL
FROM
STRUCTURED ALPHA LP
    * LIMINAL BIOSCIENCES INC - CONFIRMS THAT FOLLOWING CLOSE OF
MARKETS ON APRIL 4, 2023, BOARD RECEIVED NON-BINDING PROPOSAL
FROM STRUCTURED ALPHA LP
    * LIMINAL BIOSCIENCES INC - BOARD WILL REVIEW PROPOSAL TO
DETERMINE COURSE OF ACTION
    * LIMINAL BIOSCIENCES INC - PROPOSAL OUTLINING A POTENTIAL
TRANSACTION TO BUY ALL OF ISSUED AND OUTSTANDING COMMON SHARES
OF CO FOR $7.50 IN CASH/SHARE

Further company coverage:  LMNL.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Liminal BioSciences

See all news